Could stem cells restore ovarian function? new trial begins
NCT ID NCT07551895
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tests a single injection of stem cells from donated umbilical cords in 21 women with primary ovarian insufficiency (early menopause). The goal is to see if the treatment is safe and if it can improve hormone levels. Participants will be monitored for 24 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HS_SW01 cells (stem cells from umbilical cord)
- What this could lead to
- If it works, this could point toward a treatment that restores ovarian function and reduces the need for hormone therapy.
- What could go wrong
- This is an early phase 1/2 trial with only 21 participants, so results may not apply widely. Stem cell treatments can have unknown long-term risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY OVARIAN INSUFFICIENCY (POI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.